DS
GOSS icon

David Shaw’s Gossamer Bio GOSS Stock Holding History

David Shaw’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Buy
40,959,285
+40,569,854
+10,418% +$11.3M ﹤0.01% 2169
2026
Q1 		$128K Buy
389,431
+190,722
+96% +$300K ﹤0.01% 4263
2025
Q4 		$616K Sell
198,709
-50,109
-20% -$143K ﹤0.01% 3829
2025
Q3 		$654K Buy
248,818
+192,010
+338% +$423K ﹤0.01% 3715
2025
Q2 		$69.9K Buy
+56,808
New +$62K ﹤0.01% 4153
2024
Q2 		– Sell
-592,889
Closed -$700K – 4617
2024
Q1 		$700K Buy
592,889
+86,001
+17% +$94.7K ﹤0.01% 3310
2023
Q4 		$463K Buy
506,888
+235,578
+87% +$174K ﹤0.01% 3546
2023
Q3 		$226K Sell
271,310
-105,519
-28% -$122K ﹤0.01% 3725
2023
Q2 		$452K Buy
376,829
+240,654
+177% +$300K ﹤0.01% 3462
2023
Q1 		$172K Sell
136,175
-179,450
-57% -$344K ﹤0.01% 3932
2022
Q4 		$685K Buy
315,625
+29,867
+10% +$246K ﹤0.01% 3680
2022
Q3 		$3.42M Buy
285,758
+248,010
+657% +$3.08M ﹤0.01% 2485
2022
Q2 		$316K Sell
37,748
-5,166
-12% -$40K ﹤0.01% 4333
2022
Q1 		$372K Buy
+42,914
New +$414K ﹤0.01% 4538

Other funds holding GOSS

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

David Shaw's GOSS Position: Q2 2026 in Review

David Shaw increased its Gossamer Bio (GOSS) stake by 10,418% in Q2 2026, buying an estimated $11.3M and bringing the position to 40,959,285 shares worth $6.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

David Shaw first reported a position in GOSS in Q1 2022 and has held it in 14 quarters since. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • David Shaw held 40,959,285 shares of Gossamer Bio worth $6.74M as of Q2 2026.
  • David Shaw bought 40,569,854 Gossamer Bio shares in Q2 2026, an estimated $11.3M.
  • Gossamer Bio made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2169 holding.
  • David Shaw first reported a position in Gossamer Bio in Q1 2022 and has held it in 14 quarters since.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.